Charles River Laboratories Operating Income 2010-2023 | CRL

Charles River Laboratories annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Charles River Laboratories operating income for the quarter ending December 31, 2023 was $0.133B, a 18.86% decline year-over-year.
  • Charles River Laboratories operating income for the twelve months ending December 31, 2023 was $0.617B, a 5.18% decline year-over-year.
  • Charles River Laboratories annual operating income for 2023 was $0.617B, a 5.18% decline from 2022.
  • Charles River Laboratories annual operating income for 2022 was $0.651B, a 10.36% increase from 2021.
  • Charles River Laboratories annual operating income for 2021 was $0.59B, a 36.31% increase from 2020.
Charles River Laboratories Annual Operating Income
(Millions of US $)
2023 $617
2022 $651
2021 $590
2020 $433
2019 $351
2018 $331
2017 $288
2016 $238
2015 $206
2014 $178
2013 $151
2012 $166
2011 $174
2010 $-299
2009 $170
Charles River Laboratories Quarterly Operating Income
(Millions of US $)
2023-12-31 $133
2023-09-30 $152
2023-06-30 $165
2023-03-31 $168
2022-12-31 $164
2022-09-30 $151
2022-06-30 $187
2022-03-31 $149
2021-12-31 $173
2021-09-30 $156
2021-06-30 $138
2021-03-31 $124
2020-12-31 $129
2020-09-30 $133
2020-06-30 $77
2020-03-31 $94
2019-12-31 $109
2019-09-30 $93
2019-06-30 $80
2019-03-31 $70
2018-12-31 $102
2018-09-30 $84
2018-06-30 $77
2018-03-31 $68
2017-12-31 $63
2017-09-30 $74
2017-06-30 $82
2017-03-31 $70
2016-12-31 $69
2016-09-30 $59
2016-06-30 $58
2016-03-31 $51
2015-12-31 $52
2015-09-30 $55
2015-06-30 $56
2015-03-31 $43
2014-12-31 $41
2014-09-30 $46
2014-06-30 $51
2014-03-31 $40
2013-12-31 $25
2013-09-30 $41
2013-06-30 $43
2013-03-31 $43
2012-12-31 $35
2012-09-30 $38
2012-06-30 $49
2012-03-31 $44
2011-12-31 $42
2011-09-30 $37
2011-06-30 $53
2011-03-31 $42
2010-12-31 $-365
2010-09-30 $6
2010-06-30 $30
2010-03-31 $30
2009-12-31 $35
2009-09-30 $44
2009-06-30 $51
2009-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical Services $13.819B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $120.995B 15.70
Cencora (COR) United States $48.801B 19.48
ICON (ICLR) Ireland $27.182B 26.81
DiDi Global (DIDIY) China $18.509B 0.00
Avantor (AVTR) United States $17.350B 23.91
CochLear (CHEOY) $14.477B 0.00
Viatris (VTRS) United States $14.192B 4.05
Revvity (RVTY) United States $13.021B 22.67
Medpace Holdings (MEDP) United States $12.404B 45.41
EUROFINS SCIENT (ERFSF) Luxembourg $12.071B 0.00
Natera (NTRA) United States $10.924B 0.00
HealthEquity (HQY) United States $6.840B 51.10
Amplifon S.p.A (AMFPF) Italy $6.762B 34.33
Bausch + Lomb (BLCO) Canada $6.041B 23.26
Doximity (DOCS) United States $5.035B 37.49
Organon (OGN) United States $4.717B 4.57
Surgery Partners (SGRY) United States $3.791B 35.22
Progyny (PGNY) United States $3.666B 61.27
Sotera Health (SHC) United States $3.357B 16.49
Life Times (LTH) United States $3.031B 33.50
GoodRx Holdings (GDRX) United States $2.769B 140.20
Premier (PINC) United States $2.612B 9.56
Teladoc Health (TDOC) United States $2.551B 0.00
Agilon Health (AGL) United States $2.347B 0.00
AMN Healthcare Services Inc (AMN) United States $2.329B 7.53
BrightSpring Health Services (BTSG) United States $1.739B 0.00
NovoCure (NVCR) Jersey $1.568B 0.00
Establishment Labs Holdings (ESTA) $1.381B 0.00
Agiliti (AGTI) United States $1.376B 22.49
Alignment Healthcare (ALHC) United States $0.905B 0.00
Pediatrix Medical (MD) United States $0.840B 8.69
Embecta (EMBC) United States $0.743B 4.90
InnovAge Holding (INNV) United States $0.590B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.588B 0.00
Enhabit (EHAB) United States $0.580B 52.54
Beauty Health (SKIN) United States $0.559B 0.00
CareDx (CDNA) United States $0.545B 0.00
MultiPlan (MPLN) United States $0.544B 0.00
QDM (QDMI) Hong Kong, SAR China $0.466B 12.21
DocGo (DCGO) United States $0.423B 67.67
LifeMD (LFMD) United States $0.411B 0.00
ModivCare (MODV) United States $0.354B 4.69
Sera Prognostics (SERA) United States $0.296B 0.00
Sharecare (SHCR) United States $0.296B 0.00
Ascend Wellness Holdings (AAWH) United States $0.287B 0.00
GeneDx Holdings (WGS) United States $0.246B 0.00
Sonida Senior Living (SNDA) United States $0.237B 0.00
Biodesix (BDSX) United States $0.140B 0.00
Oncology Institute (TOI) United States $0.136B 0.00
So-Young (SY) China $0.108B 36.00
Pono Capital Two (PTWO) United States $0.070B 0.00
Nutex Health (NUTX) United States $0.068B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
NeueHealth (NEUE) United States $0.052B 0.00
SeaStar Medical Holding (ICU) United States $0.039B 0.00
Singular Genomics Systems (OMIC) United States $0.038B 0.00
Co-Diagnostics (CODX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
OncoCyte (OCX) United States $0.025B 0.00
DermTech (DMTK) United States $0.025B 0.00
BIMI Medical (BIMI) United States $0.021B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
TRxADE HEALTH (MEDS) United States $0.012B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.010B 0.00
OpGen (OPGN) United States $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
Assure Holdings (IONM) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00